email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
3046 - 3060
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
CASI Pharma Acquires 29 Generic Drug Candidates from Sandoz
$5.00
Available
Lee's Pharm to Start China Trials of In-licensed PD-L1 Candidate
$5.00
Available
ARMO, Backed by China Investors, Completes $128 Million IPO in US
$5.00
Available
Shanghai Pharma Plans San Diego Office for US/EU M&A
$5.00
Available
Generon (Shanghai) Says Neutropenia Candidate Meets Phase III Targets
$5.00
Available
Luye Considering $500 Million IPO for Healthcare Assets
$5.00
Available
Clover Using GE FlexFactory for China Biologic Manufacturing Plant
$5.00
Available
Neuspera Raises $26 Million in B Round, Led by China's 6 Dimensions
$5.00
Available
XtalPi Closes $15 Million for AI-Aided Drug Design
$5.00
Available
GSK Launches Triple-Therapy HIV Drug in China at a Low-Cost $450/Month
$5.00
Available
Tmunity Closes $100 Million Funding for T Cell Therapies; Ping An Participates
$5.00
Available
China Sees Promise, not Danger in Crispr Gene-Editing Trials
$5.00
Available
Taiwan Liposome Forms China Commercialization JV with Jixi Biotech
$5.00
Available
Harbour BioMed Raises Additional Capital in Series A+
$5.00
Available
BeiGene Completes $750 Million Secondary Offering
$5.00
Available